Receiving checks protect an already qualified cationic PAM purchase. They should distinguish identity, physical condition and application response instead of treating a COA as the whole release decision. Use checks proportionate to the treatment risk and keep discrepancies visible before the lot is consumed.
Confirm identity before comparing performance
Check the approved product code, lot marking, order and accompanying documents. Do not accept a different identity solely because the package says cationic polyacrylamide. Keep samples linked to their container and record when they were taken. If a supplier change or substitution has not been approved, receiving cannot establish equivalence merely by inspecting the powder. Use the supplier-change procedure for that technical decision.
Inspect condition and handling history
Observe package integrity, moisture exposure and visible caking under site procedures. Confirm unloading and storage arrangements before opening material. A free-flowing appearance does not independently prove chemical identity or treatment suitability. Conversely, a handling problem can compromise a qualified grade. Record abnormal observations and isolate disputed material where the plant procedure requires it, rather than blending it into approved stock to make the shipment easier to manage.
Interpret batch documents in their correct role
Review the batch document against agreed limits and methods. Product TDS characteristics and COA acceptance values are not automatically the same thing. An SDS supports safe handling rather than application qualification. Compare numerical values only when their measurement conditions are interpretable. The sample and COA checklist explains the distinction between a documentary conformity check and a sludge-performance trial.
Use reference testing when justified
For a sensitive duty, compare the received sample with an identifiable retained reference on the same representative feed and controlled preparation. A poor result should trigger investigation of feed, water, preparation and calibrated dose before assigning a cause. Do not infer that every difference proves a defective lot. Keep the material’s release or hold decision, evidence and responsible reviewer recorded so later consumption remains traceable.
Evidence needed before purchase
Record the actual observation or document reference against each item. If a condition was not tested, keep it visible as an approval limitation. Purchasing, operations and receiving should use the same candidate identifier so a favourable result is not transferred to a different product or unreviewed delivery.
| Decision | Evidence | Release condition |
|---|---|---|
| Identity | Approved code, lot and order match | Unapproved substitution is not silently consumed |
| Condition | Package integrity and moisture observations | Material remains suitable for preparation |
| Evidence | Interpretable documents and relevant reference comparison | Release or hold is supported by recorded checks |
Information to send with the quotation request
Provide the approved product and received lot identifiers, the specific discrepancy and relevant document methods. Include preparation and paired comparison data if an application response changed. Do not send an unlabeled powder sample or omit the feed change that occurred during the same period.
Include the required quantity, packaging method and destination with the technical evidence. Use the cationic PAM trial and RFQ route for a focused sample review, then confirm documents, packaging and supply scope for the approved product. Gongyi Xinqi Polymer Co., Ltd. can review the application and quotation requirements. Grade suitability, delivery availability and commercial terms need confirmation; no universal dose or guaranteed treatment outcome should be inferred from an application name.
Sample pathway
Send the feed condition and machine target.
A focused sample set starts with representative sludge, active dose, equipment and acceptance data.